Pluristem Closes $3.2 Million Private Placement

Biotechnology company Pluristem Life Systems has announced that it has completed private placements amounting to $3.2 million. The funds will be utilized to continue development of the company's proprietary stem cell expansion technology utilizing the PluriX bioreactor, increase the company's infrastructure to accommodate anticipated growth, make progress towards entry into clinical trials, and continue to explore synergistic strategic alliances.

Globes Online (http://www.globes.co.il/serveen/globes/docview.asp?did=891343&fid=942)